John W. Mcroberts Purchases 18,000 Shares of MedEquities Realty Trust Inc. (MRT) Stock
MedEquities Realty Trust Inc. (NYSE:MRT) CEO John W. Mcroberts purchased 18,000 shares of MedEquities Realty Trust stock in a transaction that occurred on Friday, November 17th. The shares were acquired at an average price of $10.74 per share, for a total transaction of $193,320.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
MedEquities Realty Trust Inc. (NYSE MRT) traded up $0.10 during mid-day trading on Monday, hitting $10.93. The company’s stock had a trading volume of 195,931 shares, compared to its average volume of 149,862. MedEquities Realty Trust Inc. has a 1 year low of $10.06 and a 1 year high of $13.06. The stock has a market cap of $343.92 and a P/E ratio of 9.85.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 29th. Stockholders of record on Wednesday, November 15th will be given a $0.21 dividend. The ex-dividend date is Tuesday, November 14th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.69%. MedEquities Realty Trust’s dividend payout ratio is currently 215.38%.
A number of brokerages recently issued reports on MRT. B. Riley restated a “buy” rating on shares of MedEquities Realty Trust in a report on Wednesday, November 1st. Capital One Financial Corporation began coverage on MedEquities Realty Trust in a report on Monday, October 23rd. They set an “equal weight” rating and a $13.00 price target on the stock. KeyCorp set a $13.00 price target on MedEquities Realty Trust and gave the company a “buy” rating in a report on Sunday, October 29th. Cantor Fitzgerald started coverage on MedEquities Realty Trust in a report on Thursday, August 31st. They set an “overweight” rating and a $14.00 target price on the stock. Finally, Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 target price on the stock in a report on Wednesday, November 15th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $12.83.
About MedEquities Realty Trust
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.